The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure

por Harouki, Najah, Nicol, Lionel, Remy-Jouet, Isabelle, Henry, Jean-Paul, Dumesnil, Anais, Lejeune, Annie, Renet, Sylvanie, Golding, Francesca, Djerada, Zoubir, Wecker, Didier, Bolduc, Virginie, Bouly, Muriel, Roussel, Jerome, Richard, Vincent, Mulder, Paul
Publicado 2017

Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits

por van Hoof, Raf H. M., Hermeling, Evelien, Sluimer, Judith C., Salzmann, Julie, Hoeks, Arnold P. G., Roussel, Jérôme, Daemen, Mat J. A. P., Struijker-Boudier, Harry, Wildberger, Joachim E., Heeneman, Sylvia, Kooi, M. Eline
Publicado 2017

Transient heart rate reduction improves acute decompensated heart failure‐induced left ventricular and coronary dysfunction

por Peschanski, Nicolas, Harouki, Najah, Soulie, Matthieu, Lachaux, Marianne, Nicol, Lionel, Remy‐Jouet, Isabelle, Henry, Jean‐Paul, Dumesnil, Anais, Renet, Sylvanie, Fougerousse, Françoise, Brakenhielm, Ebba, Ouvrard‐Pascaud, Antoine, Thuillez, Christian, Richard, Vincent, Roussel, Jérôme, Mulder, Paul
Publicado 2021